Aspiration pneumonia medical therapy

Aspiration pneumonia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Aspiration Pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Aspiration pneumonia medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Aspiration pneumonia medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Aspiration pneumonia medical therapy
CDC onAspiration pneumonia medical therapy
Aspiration pneumonia medical therapy in the news
Blogs on Aspiration pneumonia medical therapy
Directions to Hospitals Treating Pneumonia
Risk calculators and risk factors for Aspiration pneumonia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]

Overview

There is no treatment for [disease name]; the mainstay of therapy is supportive care.

OR

Supportive therapy for [disease name] includes [therapy 1], [therapy 2], and [therapy 3].

OR

The majority of cases of [disease name] are self-limited and require only supportive care.

OR

[Disease name] is a medical emergency and requires prompt treatment.

OR

The mainstay of treatment for [disease name] is [therapy].

OR   The optimal therapy for [malignancy name] depends on the stage at diagnosis.

OR

[Therapy] is recommended among all patients who develop [disease name].

OR

Pharmacologic medical therapy is recommended among patients with [disease subclass 1], [disease subclass 2], and [disease subclass 3].

OR

Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].

OR

Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].

OR

Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].

Medical Therapy

• There are different approaches for different classes of aspiration pneumonia.
• Chemical pneumonitis must be treated supportively.
• Pharmacologic medical therapy is recommended among patients with [disease subclass 1], [disease subclass 2], and [disease subclass 3].
• Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].
• Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].
• Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].

Disease Name

• 1 Chemical pneumonitis
  • 1.1 Adult
    • Preferred regimen (1): ampicillin-sulbactam 1.5-3 g IV q6h for 7 days
    • Preferred regimen (2): amoxicillin-clavulanate 875 mg PO q12h for 7 days
    • Preferred regimen (3): high molecular weight colloids IV
    • Alternative regimen (1): clindamycin 600 mg IV q8h (for penicillin-allergic patients) for 7 days
    • Alternative regimen (2): metronidazole 500 mg PO or IV q8h plus penicillin G 1-2 million units IV q4-6h for 7 days
    • Alternative regimen (3): metronidazole 500 mg PO or IV q8h plus amoxicillin 500 mg PO q8h for 7 days
    • Alternative regimen (4): metronidazole 500 mg PO or IV q8h plus ceftriaxone 1-2 g IV qd for 7 days
    • Alternative regimen (5): metronidazole 500 mg PO or IV q8h plus cefotaxime 1-2 g IV q8h for 7 days

Note (1): Immediate clearing the respiratory tract from aspirated material and fluid by suction must be the first step if the diagnosis of aspiration is definite. Note (2): Positive-pressure ventilation with 100% oxygen combined with isoproterenol to support pulmonary function is sometimes required. Note (3): The use of glucocorticoids for aspiration pneumonia is controversial.

• 2 Bacterial infection
  • 2.1 Adult
    • Preferred regimen (1): ampicillin-sulbactam 1.5-3 g IV q6h for 7 days
    • Preferred regimen (2): amoxicillin-clavulanate 875 mg PO q12h for 7 days
    • Alternative regimen (1): clindamycin 600 mg IV q8h (for penicillin-allergic patients) for 7 days
    • Alternative regimen (2): metronidazole 500 mg PO or IV q8h plus penicillin G 1-2 million units IV q4-6h for 7 days
    • Alternative regimen (3): metronidazole 500 mg PO or IV q8h plus amoxicillin 500 mg PO q8h for 7 days
    • Alternative regimen (4): metronidazole 500 mg PO or IV q8h plus ceftriaxone 1-2 g IV qd for 7 days
    • Alternative regimen (5): metronidazole 500 mg PO or IV q8h plus cefotaxime 1-2 g IV q8h for 7 days
• 3 Foreign body aspiration

Note: The best approach is to remove the foreign body by fiberoptic or rigid bronchoscopy. {{#ev:youtube|0eQlO6o_nY8}}

• 3 Foreign body aspiration